WHO Finds that Gilead’s Remdesivir has ‘little or no effect’ on COVID-19 recovery or mortality
Nevertheless, Gilead expects to make $3.5 billion from Remdesivir this year
Study Finds Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide
https://peerj.com/articles/10112/